Magentiq Eye vs Optellum Virtual Nodule Clinic
A sponsor-funded randomized tandem trial in The Lancet Digital Health enrolled 916 patients at 10 hospitals and found 0.70 adenomas per colonoscopy with the AI against 0.51 without (p=0.015), and an adenoma miss rate of 19% against 36% in the tandem substudy. Several authors report consultancy, stock options or equipment from Magentiq, and the abstract does not name the device. openFDA lists four Magentiq 510(k)s, from K223473 (July 25, 2023) to K260724 (April 3, 2026). For a gastroenterology group weighing polyp detection, that is a GI purchase, and Optellum's CT nodule software is a pulmonology and radiology one.
Optellum fits a pulmonology clinic or radiology reading room working up incidental lung nodules on CT. Its one clearance, K202300 (March 5, 2021), cites the QuantX De Novo as predicate and covers the LCP-CNN risk score for pulmonologists and radiologists. CPT Category III codes 0721T and +0722T are attached to it, and the vendor names Penn Medicine and Vanderbilt University Medical Center among its sites.
Radiology · Reviewed November 2, 2026

Magentiq Eye
by MAGENTIQ EYE · founded 2014
Real-time AI polyp detection during colonoscopy, FDA 510(k) cleared as MAGENTIQ-COLO.

Optellum Virtual Nodule Clinic
by Optellum · founded 2016
FDA-cleared AI that scores lung cancer risk for CT lung nodules and tracks them, for pulmonologists and radiology departments.
When to pick each one
Magentiq Eye
- Sponsor-funded tandem trial, 916 patients at 10 hospitals
- Adenoma miss rate 19% vs 36% in tandem substudy
- Four 510(k)s, latest K260724
Optellum Virtual Nodule Clinic
- Lung nodule risk score on CT, K202300
- CPT Category III codes 0721T and +0722T
- Integrated with RapidAI's Rapid Enterprise platform
Score
Each row shows points earned of points available under the published rubric.
Magentiq Eye
35of 100
Optellum Virtual Nodule Clinic
35of 100
| Dimension | Magentiq Eye | Optellum Virtual Nodule Clinic | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 0 / 18.2 | 0 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Magentiq Eye
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Monthly rental stated. |
Optellum Virtual Nodule Clinic
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Reimbursement fact, not a price: CPT Category III codes 0721T and +0722T; Medicare hospital outpatient APC 1508 rate $650.50 for 2026 (national average, before deductibles). |
Evidence
Magentiq Eye
FDA decisions
K260724 (opens in new tab)510(k)2026-04-03
MAGENTIQ-COLO (ME-APDS)
K252178 (opens in new tab)510(k)2025-10-03
MAGENTIQ-COLO (ME-APDS)
K244023 (opens in new tab)510(k)2025-01-24
MAGENTIQ-COLO (ME-APDS)
K223473 (opens in new tab)510(k)2023-07-25
ME-APDS; MAGENTIQ-COLO
Optellum Virtual Nodule Clinic
FDA decisions
K202300 (opens in new tab)510(k)2021-03-05
Optellum Virtual Nodule Clinic, Optellum software, Optellum platform
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Magentiq Eye | Optellum Virtual Nodule Clinic |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2014 | 2016 |
| HQ | IL | GB |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.
